Pharma Focus America
ThermoFisher Scientific - Go beyond the catalog

Aurigene Pharmaceutical Services Expanding Biologics CDMO Capacity with New Biomanufacturing Facility

Introduction:

Aurigene Pharmaceutical Services Limited, a subsidiary of Dr. Reddy's Laboratories, invests $40 million to construct a new development and manufacturing facility. 

Features:

Aurigene Pharmaceutical Services Limited is an R&D and pilot scale facility at Genome Valley, a renowned Biotechnology Park in Hyderabad.

The facility aims to meet the process development and clinical supply needs of global biotech companies.

It is designed with a state-of-the-art concept, providing maximum flexibility for a multi-product, multi-platform offering in therapeutic proteins, antibodies, and viral vectors.

The facility offers end-to-end and high-quality services for antibodies, proteins, and viral vectors.

The expansion provides global customers with access to a dedicated team, modern labs, including a pilot facility.

Exclusive access is granted to an established large-scale GMP manufacturing facility with a drug substance capacity of 15kl and fill-finish capabilities, enabling the seamless provision of commercial quantities.

The facility is planned to be fully operational in the first half of 2024.

 

Specifications:

Name:   Aurigene Pharmaceutical Services Limited 

Type:     Expansion

Year:     2024

Sartorius Lab Balance CleaningFestival of Biologics San Diego 2024Equinix accelerated medical research...World Vaccine Congress Europe 2024World Orphan Drug Congress 2024World Vaccine Congress Washington 2024Future Labs Live USA 2024Interphex 2024Pharma USA 2024Healthcare CNO SummitHealthcare CMO Summit